In a landmark development for paediatric eye care, the US Food and Drug Administration has approved the world’s first spectacles specifically designed to slow the progression of myopia in children. The lenses, known as Stellest, are developed by EssilorLuxottica and represent a decisive shift from simple vision correction to active myopia management.